← Leaderboards
Hannah Choe
Ohio State University
$1,022,976
Attributed
$2,045,952
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $415K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,045,952 · 1
By mechanism
R01$2,045,952 · 1
Top collaborators
- Parvathi Ranganathan5 shared
Most similar at Ohio State University
Same institution · by research overlap
- Sumithira Vasu$6,137,636
- Sherif S Farag$9,761,380
- Parvathi Ranganathan$1,925,208
- Yang Liu$21,443,530
- Ramiro Garzon$6,835,986
Others in their field
Other Emerging Leaders on “Complication”
- Chanza Baytop · Westat, Inc.$271,217,917
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Kimberly Smith · Ppd Development Lp$115,671,664
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Thomas Denny · Duke University$22,999,550
- Barbara Halina Braffett · George Washington University$22,016,904
Research focus
ComplicationAdrenal Cortex HormonesAffectAcute Graft Versus Host DiseaseBcl2 GeneBenzodiazepinesBiologicalBiologyBromodomainAllogenicCalcineurinCd80 GeneCd86 GeneCell CycleCell PhysiologyCell SurvivalChromatin ModificationClinical EfficacyClinical ResearchClinical TrialsCombatCombinatorialCombined Modality TherapyCorrelative Study
Grant awards (5)
Targeting epigenetic regulation via Bromodomain and Extraterminal (BET) domain inhibition for treatment of GVHD$415,000
R01 · FY2025 · CA · contact PI
Targeting epigenetic regulation via Bromodomain and Extraterminal (BET) domain inhibition for treatment of GVHD$394,251
R01 · FY2024 · CA · contact PI
Targeting epigenetic regulation via Bromodomain and Extraterminal (BET) domain inhibition for treatment of GVHD$406,701
R01 · FY2023 · CA · contact PI
Targeting epigenetic regulation via Bromodomain and Extraterminal (BET) domain inhibition for treatment of GVHD$415,000
R01 · FY2022 · CA · contact PI
Targeting epigenetic regulation via Bromodomain and Extraterminal (BET) domain inhibition for treatment of GVHD$415,000
R01 · FY2021 · CA · contact PI